Clinical Trials Browser

Terminated × Carcinoma, Transitional Cell × Everolimus × Clear all

NCT01215136 2023-11-24

First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma

Phase 2 Terminated

36 enrolled 14 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell